Citadel Advisors’s IM Cannabis IMCC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-12,246
Closed -$30.4K 13394
2025
Q2
$30.4K Buy
+12,246
New +$25.6K ﹤0.01% 11972
2024
Q4
Sell
-13,991
Closed -$33.4K 14910
2024
Q3
$33.4K Buy
13,991
+3,150
+29% +$8.04K ﹤0.01% 12330
2024
Q2
$29.9K Buy
+10,841
New +$41.6K ﹤0.01% 12276
2023
Q4
Sell
-3,839
Closed -$15.8K 14749
2023
Q3
$15.8K Buy
3,839
+985
+35% +$4.93K ﹤0.01% 12806
2023
Q2
$15.5K Buy
+2,854
New +$14.8K ﹤0.01% 12942
2022
Q3
Sell
-278
Closed -$11K 13073
2022
Q2
$11K Buy
278
+60
+28% +$4.31K ﹤0.01% 12564
2022
Q1
$28K Buy
218
+18
+9% +$2.46K ﹤0.01% 13130
2021
Q4
$40K Buy
+200
New +$39K ﹤0.01% 13367

Other funds holding IMCC

Citadel Advisors's IMCC Position: Q3 2025 in Review

Citadel Advisors sold out of IM Cannabis (IMCC) in Q3 2025, closing a stake of 12,246 shares — an estimated $30.4K sold.

Citadel Advisors first reported a position in IMCC in Q4 2021 and held it in 8 quarters. The position peaked at $40K in Q4 2021. 15 funds tracked by Wall St. Rank hold IMCC as of Q3 2025.

  • Citadel Advisors reported no remaining IM Cannabis position as of Q3 2025 after selling out during the quarter.
  • Citadel Advisors sold 12,246 IM Cannabis shares in Q3 2025, an estimated $30.4K.
  • Citadel Advisors first reported a position in IM Cannabis in Q4 2021 and held it in 8 quarters.
  • Citadel Advisors's IM Cannabis position peaked at $40K in Q4 2021.
  • 15 funds tracked by Wall St. Rank held IM Cannabis as of Q3 2025.

Based on Citadel Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.